Cargando…

The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis

OBJECTIVE: This study explored the correlation between serum HMGB1 levels and postoperative vascular restenosis in patients with lower extremity arteriosclerosis obliterans (LEASO). METHODS: A total of 362 patients LEASO who received vascular intervention were recruited in this study. Serum HMGB1 le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Bo, Xiaping, Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872960/ https://www.ncbi.nlm.nih.gov/pubmed/36704514 http://dx.doi.org/10.3389/fsurg.2022.1031108

Ejemplares similares

Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
por: Yao, Wei, et al.
Publicado: (2020)

Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Xiao, Deshuang, et al.
Publicado: (2022)

Expression and clinical significance of HSP27 and its phosphorylation in lower extremity arteriosclerosis obliterans
por: Bai, Junqing, et al.
Publicado: (2020)

Retracted: Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Zhou, Ruhang, et al.
Publicado: (2021)

Comparison of efficacy between trimetazidine and cilostazol in the treatment of arteriosclerosis obliterans in lower extremity
por: Hu, Min, et al.
Publicado: (2019)

Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans
por: Yong, Jun, et al.
Publicado: (2019)

Retracted: Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Healthcare Engineering, Journal of
Publicado: (2023)

Predictive Value of Contrast-Enhanced Ultrasound in Chemical Lumbar Sympathectomy for End-Stage Arteriosclerosis Obliterans of the Lower Extremities
por: Wu, Yue, et al.
Publicado: (2022)

Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans
por: Liu, Yulian, et al.
Publicado: (2023)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
por: Zhou, Bo, et al.
Publicado: (2020)

miR-21 regulates vascular smooth muscle cell function in arteriosclerosis obliterans of lower extremities through AKT and ERK1/2 pathways
por: Huang, Shuichuan, et al.
Publicado: (2018)

HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans
por: Chen, Keqin, et al.
Publicado: (2022)

Increased Level of Tim-3(+)PD-1(+)CD4(+)T Cells With Altered Function Might Be Associated With Lower Extremity Arteriosclerosis Obliterans
por: Cui, Liyuan, et al.
Publicado: (2022)

Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
por: Zhou, Yu, et al.
Publicado: (2023)

Effects of Drug-Coated Balloon Therapy on CT Imaging Results and Levels of Vascular Inflammatory Cytokines in Patients with Arteriosclerosis Obliterans Lesions
por: Yang, Yanlin
Publicado: (2022)

Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease
por: Zhang, Bo, et al.
Publicado: (2017)

Loss of GRB2 associated binding protein 1 in arteriosclerosis obliterans promotes host autophagy
por: Ye, Meng, et al.
Publicado: (2021)

Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
por: Yuan, You-Yuan, et al.
Publicado: (2023)

MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin-2 in arteriosclerosis obliterans of the lower extremitie
por: Huang, Shuichuan, et al.
Publicado: (2018)

A Rare Case of Thromboangiitis Obliterans of Bilateral Upper Extremities in an Adult Male
por: Ejiyooye, Toluwalope F, et al.
Publicado: (2022)

The Significance of Arteriosclerosis in the Fundus Oculi
Publicado: (1913)

Inequality in the Length of the Lower Extremities
Publicado: (1910)

Ameliorative effects of the traditional Chinese medicine formula Qing-Mai-Yin on arteriosclerosis obliterans in a rabbit model
por: Zhang, Lei, et al.
Publicado: (2020)

Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans
por: Liu, Zhenjie, et al.
Publicado: (2020)

MicroRNA-30a-3p: a potential noncoding RNA target for the treatment of arteriosclerosis obliterans
por: Zhang, Mao, et al.
Publicado: (2023)

An improved bone transport surgical method for treating chronic ischemic ulcers (thromboangiitis obliterans)
por: Zhao, Liang, et al.
Publicado: (2022)

Endovascular revascularisation versus surgical revascularisation in patients with lower limb atherosclerosis obliterans: a protocol for systematic review and meta-analysis with trial sequential analysis and meta-regression
por: Huang, Qun, et al.
Publicado: (2022)

Orthotopic kidney transplantation from a living renal donor after interventional therapy for bilateral arteriosclerosis obliterans of the iliac arteries: A case report and literature review
por: Ohyama, Takehiro, et al.
Publicado: (2023)

Effect of Recombinant Netrin-1 Protein Combined with Peripheral Blood Mesenchymal Stem Cells on Angiogenesis in Rats with Arteriosclerosis Obliterans
por: Zeng, Jie, et al.
Publicado: (2022)

TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities: A pilot retrospective study
por: Yuan, Zhao, et al.
Publicado: (2021)

The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis
por: Meng, Xiaohu, et al.
Publicado: (2018)

Angiosome-directed endovascular intervention and infrapopliteal disease: Intraoperative evaluation of distal hemodynamic changes and foot blood volume of lower extremity
por: Wang, Chaonan, et al.
Publicado: (2022)

Allograft as an Adjunct for Free Omental Flaps for Lower Extremity Coverage of a Mangled Lower Extremity
por: Brown, Madyson I, et al.
Publicado: (2023)

Arteriosclerosis
Publicado: (1925)

Arteriosclerosis
Publicado: (1913)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway
por: Lou, Xinjiang, et al.
Publicado: (2019)

Correlation of Serum CysC, IMA, and LP-PLA2 Levels With Type 2 Diabetes Mellitus Patients With Lower Extremity Atherosclerotic Occlusive Disease
por: Feng, Fen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8hmmkbbid0fn3o0s7nnsur0igc